Alesta Therapeutics
Tracked across 1 events · 6 articles · First seen Aug 19, 2026 · Last active Sep 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Alesta is the acquired company, now a wholly owned subsidiary of BioMarin. The acquisition provides a significant return for its shareholders and validates its lead asset ALE1, though its employees and non-ALE1 assets were spun out.
Aug 19, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Alesta Therapeutics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard